A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Direct Visualization of the Murine Dorsal Cochlear Nucleus for Optogenetic Stimulation of the Auditory Pathway

9.2K views

⸱

DOI:

10.3791/52426

⸱

January 20th, 2015

 ,  ,  ,  ,  ,  , 

* These authors contributed equally

In This Article

Summary

The goal of this protocol is to outline a surgical approach to provide direct access to the dorsal cochlear nucleus in a murine model.

Abstract

Investigation into the use of virus-mediated gene transfer to arrest or reverse hearing loss has largely been relegated to the peripheral auditory system. Few studies have examined gene transfer to the central auditory system. The dorsal cochlear nucleus (DCN) of the brainstem, which contains second order neurons of the auditory pathway, is a potential site for gene transfer. In this protocol, a technique for direct and maximal exposure of the murine DCN via a posterior fossa approach is demonstrated. This approach allows for either acute or survival surgery. Following direct visualization of the DCN, a host of experiments are possible, including injection of opsins into the cochlear nucleus and subsequent stimulation by an optical fiber coupled to a blue light laser. Other neurophysiology experiments, such as electrical stimulation and neural injector tracings are also feasible. The level of visualization and the duration of stimulation achievable make this approach applicable to a wide range of experiments.

Introduction

Virus-mediated gene transfer to reverse hearing loss has largely been focused on the peripheral auditory system.1 Targeting the cochlea, investigators have examined a host of delivery routes, including osmotic minipump infusion2, vector-transgene complex-soaked Gelfoam®2 or gelatin sponge3, direct microinjection4; numerous gene transfer vectors, including adeno-associated viral vectors5,6, lentiviral vectors7, and cationic liposomes2; and the dissemination of gene transfer vectors beyond the target tissue2. Most recently, adeno-associated virus (AAV)-1 has been intr....

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: All experimental procedures are performed in accordance with the Animal Care and Use Committee of the Massachusetts Eye and Ear Infirmary and Harvard Medical School, which follow national animal care guidelines, including Public Health Service Policy on Humane Care and Use of laboratory Animals, the ILAR Guide, and the Animal Welfare Act. Experimental procedures listed below detail exposure of the left DCN. Use sterile instruments while performing survival surgery.

1. Primary Craniotomy and Dorsal Cochlear Nucleus Exposure

  1. Anesthesia
    1. Anesthetize a mouse, aged 8–12 weeks, weighing 18–24 g, with xylazine 20 mg/k....

Access restricted. Please log in or start a trial to view this content.

Results

Partial Cerebellar Aspiration Demonstrates Access to the Cochlear Nucleus

After the skin and muscle overlying the skull are removed, skull surface landmarks, such as the coronal and lamda suture lines, demonstrate the approximate localization of the craniotomy. Following craniotomy with rongeurs, the cerebellum is visualized. Careful aspiration of the small portion of the cerebellum demonstrates visualization of the CN, which can then be injected (Figure 1).

Access restricted. Please log in or start a trial to view this content.

Discussion

This paper describes the technique of direct visualization of the DCN in the murine model for manipulation of the central auditory system. The outlined approach of direct visualization provides significant advantages over the main alternative, which are stereotaxic approaches. Primarily, direct visualization of the DCN allows for immediate confirmation of the site of the brainstem, whereas stereotaxic approaches do not afford direct visualization. In experiments that necessitate prolonged incubation periods, as is the ca.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

Funding: This work was supported by a Foundation Bertarelli grant (D.J.L), a MED-EL grant (D.J.L), and a National Institutes of Health Grants DC01089 (M.C.B.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Stereotaxic holderStoelting51500
Homeothermic blanketHarvard507214
Scalpel blade #11Fine Surgical Tools10011-00
Iris scissorFine Surgical Tools14084-08
5 French suctionSymmetry Surgical2777914
Dental PointsHenry Schein100-8170
Bone rongeurFine Surgical Tools16020-14
10 µl Hamilton syringeHamilton 7633-01
34 gauge, needleHamilton 207434
RongeursFine Surgical Tools16021-14

References

  1. Lalwani, A., Mhatre, A. Cochlear gene therapy. Ear Hear. 24 (4), 342-348 (2003).
  2. Lalwani, A., Jero, J., Mhatre, A. Current issues in cochlear gene transfer. Audiol Neurootol. 7 (3), 146-151 (2002).
  3. Jero, J., et al.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Virus Mediated Gene TransferCraniotomy TechniqueCerebellar AspirationOptical Fiber StimulationBlue Light LaserAuditory Brainstem ResponseMicroinjection Technique